Table 1:

General clinical and radiologic characteristics of the whole population and in patients with complete reperfusion

Whole Cohort (n = 236)mTICI 3 Subgroup (n = 127)
Age (mean) (SD) (yr)68.7 (14.6)68.8 (14.2)
Female sex (No.) (%)116 (49.2)62 (49.2)
Baseline NIHSS score (median) (IQR)11 (17–21)16 (9–20)
Hypertension (No.) (%)132 (55.9)68 (53.5)
Diabetes mellitus (No.) (%)34 (14.4)21 (16.5)
Atrial fibrillation (No.) (%)70 (29.7)37 (29.1)
Previous stroke (No.) (%)22 (9.3)11 (8.7)
Time from symptom onset to CTP study (median) (IQR) (min)167 (88–270)150 (77–281)
Time from CTP to MRI study (median) (IQR) (hr)34.9 (22.5–61.3)30.9 (20.9–62.2)
TOAST (No.) (%)33
    Atherosclerotic35 (14.8)22 (12.7)
    Cardioembolic120 (50.8)63 (49.6)
    Undetermined67 (28.4)36 (28.3)
    Infrequent14 (6)6 (4.7)
mTICI score (No.) (%)
    021 (8.9)0 (0)
    17 (3)0 (0)
    2a18 (7.6)0 (0)
    2b63 (26.7)0 (0)
    3127 (53.8)127 (100)
Collateral status (median) (IQR)2 (1–3)2 (2–3)
CBF (median) (IQR) (mL/100 g/min)2.4 (2.2–2.6)2.4 (2.2–2.6)
CBV (median) (IQR) (mL/100 g/min)24.3 (20.5–26.9)24.3 (20.5–26.5)
MTT (median) (IQR) (sec)6.0 (5.5–6.5)6.1 (5.5–6.6)
NVT (median) (IQR) (mL)19.3 (8.0–34.5)16.0 (7.4–33.0)
FIV (median) (IQR) (mL)19.6 (7.4–51.0)14.0 (3.6–58.4)
  • Note:—mTICI indicates modified TICI.